Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (13312)	1/14/1998 7:05:00 PM
From: Henry Niman	Read Replies (2) of 32384

Andy, The Panretin combinations trials with Tamoxifen are government sponsored by individual investigators. They are small Phase I trials. I thought I saw a Targretin combination trial many months ago, but since I haven't found it, I'm not sure (Ligand Links will help organize all of this info). I'm guessing that Targretin is compasionate use for Breast Cancer because I haven't seen an announcement of the start of a trial. However, LGND has so many trials going, that some may start unannounced. Targretin has already completed Phase I/IIa trials for cancer, so I would expect a Breast Cancer treatment trial to begin at the II/III Phase.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next